Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human FGF1 ELISA Kit (AC3265)
Cat.#: ASET-1854
Specifications
Description Human FGF1 ELISA Kit allows for the in vitro quantitative determination of human FGF1 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1669 Mouse Cathepsin G ELISA Kit (AC3080) Quantitative inquiry ASET-1477 Mouse CaMKII beta ELISA Kit (AC2888) Quantitative inquiry ASET-1752 Human Otx2 ELISA Kit (AC3163) Quantitative inquiry ASET-1603 Human KCNQ1 ELISA Kit (AC3014) Quantitative inquiry ASET-2535 Mouse Kappa Opioid Receptor ELISA Kit (AC3946) Quantitative inquiry ASET-1438 Human COLEC12 ELISA Kit (AC2849) Quantitative inquiry ASET-1084 Mouse C1qtnf5 ELISA Kit (AC2495) Quantitative inquiry ASET-2466 Human OLFML2B ELISA Kit (AC3877) Quantitative inquiry ASET-1320 Porcine Myelin Basic Protein ELISA Kit (AC2731) Quantitative inquiry ASET-1547 Mouse Synaptophysin ELISA Kit (AC2958) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket